Ronald R. Magness

ORCID: 0000-0003-4680-5069
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Estrogen and related hormone effects
  • Nitric Oxide and Endothelin Effects
  • Reproductive Physiology in Livestock
  • Reproductive System and Pregnancy
  • Cardiovascular Issues in Pregnancy
  • Neonatal Respiratory Health Research
  • Maternal and fetal healthcare
  • Renin-Angiotensin System Studies
  • Gestational Diabetes Research and Management
  • Endometriosis Research and Treatment
  • Menopause: Health Impacts and Treatments
  • Angiogenesis and VEGF in Cancer
  • Inflammatory mediators and NSAID effects
  • Blood Coagulation and Thrombosis Mechanisms
  • Pulmonary Hypertension Research and Treatments
  • Prenatal Substance Exposure Effects
  • Hormonal Regulation and Hypertension
  • Animal Behavior and Welfare Studies
  • Ovarian function and disorders
  • Connexins and lens biology
  • Eicosanoids and Hypertension Pharmacology
  • Cancer Risks and Factors
  • Fatty Acid Research and Health

University of South Florida
2016-2024

University of Wisconsin–Madison
2010-2019

Meriter Hospital
1999-2019

UnityPoint Health Meriter
2019

University of Iowa Stead Family Children’s Hospital
2018

The University of Texas Medical Branch at Galveston
2012-2013

Orthopaedic Research Laboratories
1998-2012

Pediatrics and Genetics
2002-2012

Lawrence University
2012

Spelman College
2011

Systemic estradiol-17 beta (E2 beta) administration increases uterine blood flow (UBF), cardiac output (CO), heart rate (HR), and plasma renin activity (PRA). We sought to determine if the E2 beta-induced systemic responses were dependent on observed responses. Nonpregnant, ovariectomized ewes (n = 5) received 3 micrograms into both arteries followed 120 min later by beta, 1 microgram/kg. At after local UBF increased from 26 +/- 5 161 21 ml/min (P less than 0.05); vascular resistance (UVR)...

10.1152/ajpendo.1989.256.4.e536 article EN AJP Endocrinology and Metabolism 1989-04-01

Estradiol-17beta (E2beta), a potent vasodilator, has its greatest effects on the uterine vasculature, blood flow (UBF) increasing > or = 10-fold. The mechanism(s) responsible for E2beta-induced vasodilation is unclear. We determined if nitric oxide (NO)-induced increases in cGMP modulate estrogen-induced UBF, and cyclooxygenase inhibition modifies E2beta responses. Nonpregnant (n 15) pregnant 8) ewes had probes implanted main arteries catheters branches of vein artery bilaterally sampling...

10.1172/jci119022 article EN Journal of Clinical Investigation 1996-11-01

Estrogens and estrogen metabolites have important functions in cardiovascular other physiology, yet the patterns of synthesis, metabolism, individual plasma profile estrogens during human pregnancy as well preeclampsia remain undetermined. We performed liquid chromatography mass spectrometry on samples from normotensive pregnant women (normP; n=8), with mild (mPE; severe (sPE; n = 8) at labor. Compared normP, estrone was lower sPE, whereas level estradiol-17β significantly mPE sPE. Estriol...

10.1161/hypertensionaha.111.201624 article EN Hypertension 2013-01-15

Studies in rats and mice have established that maternal nutrition induces epigenetic modifications, sometimes permanently, alter gene expression the fetus, which turn leads to phenotypic changes. However, limited data is available on influence of diet modifications sheep. Therefore, objectives this study were investigate impact different dietary energy sources imprinted genes fetuses Ewes naturally bred a single sire from days 67 ± 3 gestation until necropsy (days 130 1), they fed one three...

10.3389/fgene.2013.00049 article EN cc-by Frontiers in Genetics 2013-01-01

Rapid uterine vasodilatation after estrogen administration is believed to be mediated by endothelial production of nitric oxide (NO) via NO synthase (eNOS). However, the mechanism(s) which activates eNOS in artery cells (UAEC) unknown. In this study, we observed that estradiol-17beta (E2) and E2-BSA rapidly (<2 min) increased total NOx UAEC vitro. This was associated with rapid phosphorylation activation but unaltered pretreatment actinomycin-D. Estrogen receptor-alpha protein detectable...

10.1210/en.2003-0547 article EN Endocrinology 2003-09-30

Vascular endothelial growth factor (VEGF) is a potent regulator of placental vascular function. Endothelial dysfunction key associated with preeclampsia. In this study, we examined expression VEGF, endocrine gland-derived VEGF (EG-VEGF), receptors 1 and 2 (VEGFR-1 VEGFR-2), neuropilin-1 -2 (NP-1 NP-2) in human placentas from women normal preeclamptic (PE) pregnancies using quantitative or semiquantitative PCR. We found that total mRNA was increased 2.8-fold (P < 0.05), along increases...

10.1210/jc.2003-031580 article EN The Journal of Clinical Endocrinology & Metabolism 2004-05-01

Angiotensin II has been identified immunohistochemically in the ovaries of both rats and humans. Here we present evidence that angiotensin (an extremely vasoactive agent a wide range tissues) may be involved regulation major steroidogenic enzyme ovary, cholesterol side chain cleavage cytochrome P-450 (P-450scc), as well basic fibroblast growth factor (bFGF), which implicated an angiogenic bovine corpus luteum. We have used primary cultures luteal cells to examine effect its receptor...

10.1016/s0021-9258(19)40185-3 article EN cc-by Journal of Biological Chemistry 1990-01-01

Preeclampsia (PE) is a common cause of maternal morbidity, characterized by impaired trophoblast invasion and spiral artery transformation resulting in progressive uteroplacental hypoxia. Given the primary role LIN28A LIN28B modulating cell metabolism, differentiation, invasion, we hypothesized that and/or regulates differentiation its dysregulation may contribute to PE. Here show expressed ∼1300-fold higher than human term placenta predominant paralog cultures. The expression mRNA protein...

10.1096/fj.201801163r article EN The FASEB Journal 2018-10-11

Uterine blood flow (UBF) and uterine artery endothelial nitric oxide synthase (eNOS) expression are greatest during the follicular vs. luteal phase. 17β-Estradiol (E 2 β) increases UBF elevates eNOS in ovine but not systemic arteries; progesterone (P 4 ) effects on E β changes of remain unclear. Nonpregnant ovariectomized sheep received either vehicle ( n = 10), P (0.9 g Controlled Internal Drug Release vaginal implants; 13), (5 μg/kg bolus + 6 μg · kg −1 day ; or 12). Reproductive...

10.1152/ajpheart.2001.280.4.h1699 article EN AJP Heart and Circulatory Physiology 2001-04-01

During pregnancy, the uterine vasculature shows a marked increase in vasodilator production [prostacyclin (PGI2) and nitric oxide (NO)] response to number of agonists including angiotensin II (AII) ATP. As consequence vascular resistance is kept low, blood flow maximized meet needs growing fetus. Studies molecular basis underlying this change control endothelial NO PGI2 have been hampered by lack availability suitable cell model. To that end we developed characterized new ovine artery (UAEC)...

10.1210/endo.141.3.7367 article EN Endocrinology 2000-03-01

To define the role of endothelial nitric oxide (NO) in developmental changes pulmonary vascular resistance and oxygen responsiveness, we determined ontogeny NO production modulation that process arteries from fetal newborn lambs. was assessed by measuring endothelium-dependent arterial guanosine 3',5'-cyclic monophosphate synthesis. Basal rose two-fold late gestation to 1 wk age another 1.6-fold 4 wk. Acetylcholine-stimulated also increased The maturational rise evident at high Po2 vitro, it...

10.1152/ajpheart.1993.265.4.h1056 article EN AJP Heart and Circulatory Physiology 1993-10-01

During the follicular phase of ovarian cycle, when local estrogen-to-progesterone ratio is elevated, uterine blood flow elevated. This vasodilatory response reproduced by exogenous 17β-estradiol (E 2 β) administration via a nitric oxide (NO)-mediated mechanism. We hypothesized that endogenous estrogen and E β treatment elevate expression endothelial cell-derived NO synthase (eNOS) in uterine, but not systemic, arteries. Uterine, mammary, systemic (renal and/or omental) arteries were...

10.1152/ajpheart.1998.275.5.h1845 article EN AJP Heart and Circulatory Physiology 1998-11-01

Prolonged 17β-estradiol (E 2 β) infusion decreases mean arterial pressure (MAP) and systemic vascular resistance (SVR) while increasing heart rate (HR) cardiac output (CO). It is unclear, however, which beds show increases in perfusion. The purpose of this study was to determine reproductive nonreproductive exhibit alterations blood flow during prolonged E β infusion. Nonpregnant, ovariectomized sheep received either vehicle ( n = 6) or (5 μg/kg iv bolus followed by 6 over 24 h for 10 days;...

10.1152/ajpheart.1998.275.3.h731 article EN AJP Heart and Circulatory Physiology 1998-09-01

Human and ovine pregnancies are associated with increases in plasma levels of estrogens angiotensin II (ANG II), cardiac output (CO), blood volume (BV), uterine flow (UBF), as well attenuated ANG pressor responses. We hypothesized that, nonpregnant animals, prolonged estradiol-17 beta (E2 beta) treatment would reproduce these endocrine hemodynamic alterations. Nonpregnant ovariectomized ewes (n = 5) received 5 microgram E2 beta/kg iv followed by 220 micrograms/day for 14 days. Plasma...

10.1152/ajpendo.1993.265.5.e690 article EN AJP Endocrinology and Metabolism 1993-11-01

Uterine vasculature is less responsive than systemic to angiotensin II (ANG II)-induced vasoconstriction. We hypothesized that pregnancy augments basal and ANG II-stimulated endothelial prostacyclin (PGI2) and/or nitric oxide (NO) production, which locally increase vascular smooth muscle (VSM) adenosine 3',5'-cyclic monophosphate (cAMP) guanosine (cGMP), respectively. (UA) arteries (SA) from pregnant (P) nonpregnant (NP) sheep were incubated with isobutylmethylxanthine. Basal PGI2, cAMP,...

10.1152/ajpheart.1996.270.6.h1914 article EN AJP Heart and Circulatory Physiology 1996-06-01

Estradiol-17β (E 2 β) and its metabolites, which are sequentially synthesized by cytochrome P450s catechol- O -methyltransferase to form 4-hydroxyestradiol (OHE ) 2- 4-methoxestradiol (ME ), elevated during pregnancy. We investigated whether expressed in uterine artery endothelial cells (UAECs) E β metabolites modulate cell proliferation via ER-α and/or ER-β play roles physiological angiogenesis Cultured ovine UAECs from pregnant nonpregnant ewes were treated with 0.1 100.0 nmol/L of β,...

10.1161/hypertensionaha.109.146399 article EN Hypertension 2010-03-09
Coming Soon ...